Literature DB >> 12171948

Protagonist: endoscopic surveillance of patients with Barrett's oesophagus.

H Barr1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12171948      PMCID： PMC1773343          DOI： 10.1136/gut.51.3.313

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  20 in total

Review 1.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 2.  Standard resection for cancer of the esophagus and cardia.

Authors:  F H Ellis
Journal:  Surg Oncol Clin N Am       Date:  1999-04       Impact factor: 3.495

3.  Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus.

Authors:  E Bollschweiler; W Schröder; A H Hölscher; J R Siewert
Journal:  Br J Surg       Date:  2000-08       Impact factor: 6.939

4.  Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus.

Authors:  C Ell; A May; L Gossner; O Pech; E Günter; G Mayer; R Henrich; M Vieth; H Müller; G Seitz; M Stolte
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

5.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

Authors:  J Lagergren; R Bergström; A Lindgren; O Nyrén
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

Review 6.  Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy.

Authors:  H Barr
Journal:  Gastrointest Endosc Clin N Am       Date:  2000-07

7.  The Vienna classification of gastrointestinal epithelial neoplasia.

Authors:  R J Schlemper; R H Riddell; Y Kato; F Borchard; H S Cooper; S M Dawsey; M F Dixon; C M Fenoglio-Preiser; J F Fléjou; K Geboes; T Hattori; T Hirota; M Itabashi; M Iwafuchi; A Iwashita; Y I Kim; T Kirchner; M Klimpfinger; M Koike; G Y Lauwers; K J Lewin; G Oberhuber; F Offner; A B Price; C A Rubio; M Shimizu; T Shimoda; P Sipponen; E Solcia; M Stolte; H Watanabe; H Yamabe
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

8.  Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study.

Authors:  F T Peters; S Ganesh; E J Kuipers; W J Sluiter; E C Klinkenberg-Knol; C B Lamers; J H Kleibeuker
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

Review 9.  Barrett's esophagus. Reducing the risk of progression to adenocarcinoma.

Authors:  J C Reynolds; M Waronker; M S Pacquing; R R Yassin
Journal:  Gastroenterol Clin North Am       Date:  1999-12       Impact factor: 3.806

10.  Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia.

Authors:  P Sharma; A P Weston; T Morales; M Topalovski; M S Mayo; R E Sampliner
Journal:  Gut       Date:  2000-01       Impact factor: 23.059
View more
  2 in total

Review 1.  Endoscopic screening and surveillance for Barrett's esophagus--clinical implications.

Authors:  Hugh Barr; Catherine Kendall; Florain Bazant-Hegemark; Paul Moayyedi; G Shetty; Nicholas Stone
Journal:  MedGenMed       Date:  2006-06-27

2.  Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features.

Authors:  Fumiaki Sato; Zhe Jin; Karsten Schulmann; Jean Wang; Bruce D Greenwald; Tetsuo Ito; Takatsugu Kan; James P Hamilton; Jian Yang; Bogdan Paun; Stefan David; Alexandru Olaru; Yulan Cheng; Yuriko Mori; John M Abraham; Harris G Yfantis; Tsung-Teh Wu; Mary B Fredericksen; Kenneth K Wang; Marcia Canto; Yvonne Romero; Ziding Feng; Stephen J Meltzer
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.